🎉   Please check out our new website over at books-etc.com.

Seller
Your price
£103.25
RRP: £139.99
Save £36.74 (26%)
Printed on Demand
Dispatched within 14-21 working days.

Biosimilars

Regulatory, Clinical, and Biopharmaceutical Development. AAPS Advances in the Pharmaceutical Sciences Series 34

Format: Hardback
Publisher: Springer International Publishing AG, Cham, Switzerland
Published: 29th Dec 2018
Dimensions: w 156mm h 234mm d 40mm
Weight: 1200g
ISBN-10: 3319996797
ISBN-13: 9783319996790
Barcode No: 9783319996790
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe.

New & Used

Seller Information Condition Price
-New£103.25
+ FREE UK P & P

What Reviewers Are Saying

Be the first to review this item. Submit your review now